相关实验视频
Updated: Jun 25, 2025

06:14
Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus
Published on: May 13, 2021
6.5K
细胞因子武装的型疹简单病毒:在癌症免疫治疗中改变游戏规则?
Hongbin Wang1,2, Mia Borlongan2, Howard L Kaufman3,4
1Department of Pharmaceutical and Biomedical Sciences, California Northstate University College of Pharmacy, Elk Grove, California, USA.
Journal for immunotherapy of cancer
|May 31, 2024
概括
瘤病毒,如talimogene laherparepvec,可以提供细胞因子有效载荷来增强抗瘤免疫力. 这篇评论探讨了各种细胞因子,以优化癌症治疗的型病毒免疫疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 在瘤学瘤学.
背景情况:
- 细胞因子对于免疫细胞调节至关重要,并且有几种已批准的癌症疗法.
- 瘤病毒直接杀死瘤细胞,并刺激免疫反应对抗癌症.
- 塔利莫基因laherparepvec是一种瘤性简单疹病毒1型 (oHSV),编码粒细胞巨细胞殖民地刺激因子 (GM-CSF),并已被批准用于黑色素瘤.
研究的目的:
- 审查细胞因子和化学因子有效载荷在增强瘤性病毒 (oHSV) 抗瘤免疫力的作用.
- 讨论各种细胞因子和化学因子作为oHSV的有效载荷的初步数据.
- 探索最佳的细胞因子选择如何可以改善型病毒免疫疗法的临床结果.
主要方法:
- 对oHSV中细胞因子和化学因子有效载荷的初步数据的审查.
- 分析不同细胞因子 (如GM-CSF,IL-12,IL-15) 对抗瘤免疫力的影响.
- 检查细胞因子组合的增强治疗效果.
主要成果:
- 瘤病毒可以有效地将治疗性细胞因子有效载荷传递到瘤部位.
- 包括GM-CSF,IL-12和IL-15在内的各种细胞因子和化学因子显示出增强oHSV介导的抗瘤免疫力的潜力.
- 细胞因子的组合可能在驱动免疫反应方面提供协同效益.
结论:
- 通过oHSV传递细胞因子是一种增强抗瘤免疫力的有希望的策略.
- 进一步了解最佳的细胞因子有效载荷对于改善型病毒免疫疗法至关重要.
- 增强的细胞因子有效载荷可以为接受oHSV治疗的癌症患者带来更好的临床益处.
相关概念视频
Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514
Cancer Vaccines
354
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
354
Mechanisms of Retrovirus-induced Cancers
5.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K

